INNOVATIVE TREATMENT STRATEGIES FOR PATIENTS WITH OVERACTIVE BLADDER AND URGE INCONTINENCE NOT CAUSED BY OBSTRUCTION

dc.contributor.author	Kasimov S. S.
dc.contributor.author	Rahmonberdiyev Kh. K.
dc.date.accessioned	2025-12-28T10:43:48Z
dc.date.issued	2025-10-29
dc.description.abstract	Overactive bladder (OAB) is observed in approximately 25% of patients with various urinary tract disorders, with urge urinary incontinence present in about one-third of these cases. The objective of this study was to enhance treatment outcomes in women with OAB, urge urinary incontinence, and non-obstructive urination by employing a combined pharmacological approach using an α1-adrenergic blocker and an M-anticholinergic agent. Additionally, the study aimed to investigate the correlation between clinical symptoms and urodynamic parameters, as well as assess changes in bladder mucosal microcirculation before and after therapy.
dc.format	application/pdf
dc.identifier.uri	https://usajournals.org/index.php/1/article/view/1288
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/4100
dc.language.iso	eng
dc.publisher	Modern American Journals
dc.relation	https://usajournals.org/index.php/1/article/view/1288/1371
dc.rights	https://creativecommons.org/licenses/by/4.0
dc.source	Modern American Journal of Medical and Health Sciences; Vol. 1 No. 7 (2025); 228-236
dc.source	3067-803X
dc.title	INNOVATIVE TREATMENT STRATEGIES FOR PATIENTS WITH OVERACTIVE BLADDER AND URGE INCONTINENCE NOT CAUSED BY OBSTRUCTION
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: s_2025_innovative_treatment_strategies_for_pati.pdf
item.page.filesection.size: 373.28 KB
item.page.filesection.format: Adobe Portable Document Format